Silq
The startup has developed a biocompatible surface treatment technology that modifies substrates to enhance specific surface properties such as biofilm resistance and anti-thrombogenicity without altering their bulk characteristics. This technology helps medical professionals reduce catheter obstruction and leakage caused by sediment and debris accumulation.
Traction –/10
Los Angeles, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a biocompatible surface treatment technology that modifies substrates to enhance specific surface properties such as biofilm resistance and anti-thrombogenicity without altering their bulk characteristics. This technology helps medical professionals reduce catheter obstruction and leakage caused by sediment and debris accumulation.